Formulation and evaluation of Costus igneus herbal lollipops for diabetes management

Saidatri Arige; Lakshmana Rao A; Vinod Kumar  V.L; Devika M; Veena Sree P P; Rama Krishna  T.P

doi:10.56782/pps.308

Published : 2025-04-22

Vol. 23 No. 2 (2025)

Formulation and evaluation of Costus igneus herbal lollipops for diabetes management

Saidatri Arige

Lakshmana Rao A

Vinod Kumar V.L

Devika M

Veena Sree P P

Rama Krishna T.P

DOI: https://doi.org/10.56782/pps.308

Abstract

Objectives: This study aims to develop and evaluate the efficacy of herbal lollipops incorporating Costus igneus extract for diabetes management. Materials and Methods: The powdered Costus igneus material was subjected to extraction using ethanol by Soxhlet extraction method. The extract was filtered and concentrated under reduced pressure to obtain a concentrated extract. Various formulations of herbal lollipops were prepared using different concentrations of Costus igneus extract, along with suitable excipients like stevia, binder and colors. Results: The formulated lollipops showed the uniformity in weight and thickness. The hardness of all formulated lollipops was found within the standard range up to 9.65 to 10.50 kg/cm². From the in-vitro drug release study, it was found that the formulations of lollipops containing corn syrup in the concentrations of 100, 90 and 80 mg showed the maximum drug release at 30 minutes. Among those formulations formulation F9 showed 100.6% of drug release. The in-vitro release kinetic study of the optimized formulation (F9) was found to be first order. The release of the dosage form follows the diffusion and dissolution mechanism and Non-Fickian diffusion mechanism. Conclusion: These findings suggest that herbal lollipops containing Costus igneus hold promise as a novel and effective alternative for managing diabetes.

Keywords:

Costus igneus, Diabetes, Soxhlet extraction, herbal lollipops

Similar Articles

Agnieszka Białek, Andrzej Tokarz, DIETARY SOURCES AND BENEFICIAL HEALTH EFFECTS OF CONJUGATED LINOLEIC ACIDS (CLA) , Prospects in Pharmaceutical Sciences: Vol. 7 No. 1 (2009)
Dibyajyoti Saha, Satish Kumar Sarankar, Critical review on potentials of ethnopharmacological, ethnomedicinal and traditional practices of Madhuca longifolia (J. Koenig Ex L.) J. F. Macbr. (Family: Sapotaceae) , Prospects in Pharmaceutical Sciences: Vol. 21 No. 2 (2023)
Celal Bal, Emre Cem Eraslan, Mustafa Sevindik, Antioxidant, antimicrobial activities, total phenolic and element contents of wild edible mushroom Bovista nigrescens , Prospects in Pharmaceutical Sciences: Vol. 21 No. 2 (2023)
Falah Saleh Mohammed, Mustafa Sevindik, İmran Uysal, Ali Erdem Sabik, Quercetin: derivatives, biosynthesis, biological activity, pharmacological and therapeutic effects , Prospects in Pharmaceutical Sciences: Vol. 21 No. 3 (2023)
Ali İmran Korkmaz, Celal Bal, Emre Cem Eraslan, Mustafa Sevindik, Hasan Akgul, Biological activities of Agrocybe praecox (spring fieldcap mushroom) , Prospects in Pharmaceutical Sciences: Vol. 21 No. 4 (2023)
Agnieszka Lis-Cieplak, ADAMANTANE DERIVATIVES - VARIETY OF BIOLOGICAL ACTIVITIES. A REVIEW OF MEDICATIONS APPROVED IN POLAND AND POTENTIAL DRUGS , Prospects in Pharmaceutical Sciences: Vol. 10 No. 3 (2012)
Adam Piasecki, Magdalena Sitnik, Jakub Olszewski, Maciej Bara, Katarzyna Herjan, Piotr Armański, The changing landscape of mineralocorticoid receptor antagonists – finerenone in cardiovascular and renal health , Prospects in Pharmaceutical Sciences: Vol. 22 No. 1 (2024)
Martyna Chechłacz, Natalia Korytowska, COMPOUNDS THAT BIND TO PLASMA PROTEINS IN HUMANS. SIGNIFICANCE IN THERAPY AND METHODS FOR QUANTIFICATION OF A FREE FRACTION , Prospects in Pharmaceutical Sciences: Vol. 15 No. 6 (2017)
Barbara Krzemińska, Gabriela Szewczyk, Cotoneaster horizontalis Decne. (Rosaceae) - medicinal or just ornamental species? , Prospects in Pharmaceutical Sciences: Vol. 22 No. 2 (2024)
Ali İmran Korkmaz, Celal Bal, Tetiana Krupodorova, Mehmet Ali Yüzbaşıoğlu, Beste Gizem Özbey Sarıdoğan, Mustafa Sevindik, Some biological activities and element levels of Lycoperdon pratense , Prospects in Pharmaceutical Sciences: Vol. 22 No. 2 (2024)

<< < 1 2 3 4 > >>

You may also start an advanced similarity search for this article.

Details

References

Statistics

Authors

Download files

PDF

Citation rules

Arige, S., Rao A, L., V.L, V. K., M, D., P, V. S. P., & T.P, R. K. (2025). Formulation and evaluation of Costus igneus herbal lollipops for diabetes management. Prospects in Pharmaceutical Sciences, 23(2), 10–18. https://doi.org/10.56782/pps.308

Altmetric indicators

Cited by / Share

Licence

This work is licensed under a Creative Commons Attribution 4.0 International License.

References

1. Shinde, S. P.; Kondhalkar, S. M. A review on insulin plant (Costus igneus L.) and its remedial approaches. Asian J. Res. Bot. 2025, 8(1), 14–21. DOI: 10.9734/ajrib/2025/v8i1238

2. Athilli, L.; Siddiqui, A. F.; Hussain, F.; Parvez, E. A. H. Pharmacognostic study and pharmacological potentials of Costus igneus plant – Review. Int. J. Pharmacogn. 2021, 8(12), 476–486. DOI: 10.13040/IJPSR.0975-8232.IJP.8(12).476-86

3. Laha, S.; Paul, S. Costus igneus – A therapeutic anti-diabetic herb with active phytoconstituents. Int. J. Pharm. Sci. Res. 2019, 10(8), 3583–3591. DOI: 10.13040/IJPSR.0975-8232.10(8).3583-91

4. Shubham, K.; Mittal, A.; Babu, D.; Mittal, A. Herbal medicines for diabetes management and its secondary complications. Curr. Diabetes Rev. 2021, 17(4), 437–456. DOI: 10.2174/1573399816666201103143225

5. Azhagu Madhavan, S.; Ganesan, S.; Sripriya, R.; Priyadharshini, R. A literature review of anti-diabetic medicinal plant properties (Costus species). J. Biomed. Res. Environ. Sci. 2021, 2(5), 305–310. DOI: 10.37871/jbres1231

6. Khandale, S. N.; Sonavane, M. Potential therapeutic efficacy of Costus igneus for diabetes mellitus & other diseases with framework for its evaluation based on Ayurveda. Int. J. Adv. Res. 2019, 7(12), 813–818. DOI: 10.21474/IJAR01/10215

7. Shivaprakash, G.; Thottacherry, E. D.; Rai, S.; Nandini, M.; Kumarachandra, R. Evaluation of antioxidant potential of Costus igneus in ethanol induced peroxidative damage in albino rats. J. Appl. Pharm. Sci. 2014, 4(8), 052–055. DOI: 10.7324/JAPS.2014.40810

8. Vinotha, V.; Iswarya, A.; Thaya, R.; Govindarajan, M.; Alharbi, N. S.; Kadaikunnan, S.; et al. Synthesis of ZnO nanoparticles using insulin-rich leaf extract: Anti-diabetic, antibiofilm and antioxidant properties. J. Photochem. Photobiol. B: Biol. 2019, 197, Art. No: 111541. DOI: 10.1016/j.jphotobiol.2019.111541

9. Talasila, E. G. K.; Bavirisetti, H.; Chimakurthy, J.; Candasamy, M. Effect of Costus igneus: The insulin plant, on pre-diabetes and diabetes in neonatal streptozotocin rats. J. Health Sci. 2014, 4(3), 162–168. DOI: 10.17532/jhsci.2014.163

10. Chandrakar, N.; Kaur, J.; Banerjee, M. Synergies of bioactivities, mechanisms, dietary factors and functional food applications of medicinal insulin plant (Costus pictus D.): A review. Int. J. Food Sci. Technol. 2024, 59, 8933–8942. DOI: 10.1111/ijfs.17588

11. Josephine, I. G.; Punnagai, K. In vitro cytotoxicity activity of ethanolic leaf extract of Costus igneus against hepatocellular carcinoma (HepG2) cells. Biomed. Pharmacol. J. 2024, 17, Art. No: 1715. DOI: 10.13005/bpj/1715

12. Dhone, P. G.; Goyal, M.; Sahu, Y. P.; Mubeen, M. F. To evaluate antioxidant activity of Costus igneus in ethanol induced peroxidative damage in albino rats. Int. J. Health Sci. 2022, 6(S5), Art. No: 9858. DOI: 10.53730/ijhs.v6nS5.9858

13. Ratnakar, S. M; Prakash S. B. Phytochemical analysis of different solvent extracts of Costus igneus. Int. J. Food Nutrit. Sci. 2022, 11(12), 2364-2368

14. Jadhav, G.; Pagire, D.; Jadhav, V. Formulation and evaluation of anti-diabetic tablet from insulin plant (Costus igneus). Int. J. Multidiscip. Res. 2023, 5(3), Art. No: IJFMR23032976

15. Prabhu, P. P.; Malli, R.; Koland, M.; Vijaynarayana, K.; D’Souza, U.; Harish, N. M.; Shastry, C. S.; Charyulu, R. N. Formulation and evaluation of fast dissolving films of levocetirizine dihydrochloride. Int. J. Pharm. Investig. 2011, 1(2), 99–104. DOI: 10.4103/2230-973X.82417

16. Jacob, S.; Boddu, S. H. S.; Bhandare, R.; Shabbir, S. Orodispersible films: Current innovations and emerging trends. Pharmaceutics 2023, 15(12), Art. No: 2753. DOI: 10.3390/pharmaceutics15122753

17. Alburyhi, M. M.; Noman, M. A.; Saif, A. A.; Mohamed, Y. A. S.; Hamidaddin, M. A.; Yahya, T. A. A.; Al-Ghorafi, M. A.; Abdullah, J. H. Lisinopril-excipient compatibility studies for advanced drug delivery systems development. World J. Pharm. Res. 2024, 13(16), 59–111. DOI: 10.20959/wjpr202416-33678

18. Singh, C.; Rao, K.; Yadav, N.; Bansal, N.; Vashist, Y.; Kumari, S.; Chugh, P. A review: Drug-excipient incompatibility by FTIR spectroscopy. Curr. Pharm. Anal. 2023, 19(5), 371–378. DOI: 10.2174/1573412919666230228102158

19. Alburyhi, M. M.; Noman, M. A.; Saif, A. A.; Hamidaddin, M. A.; Yahya, T.A.A.; Abd-hafiz Al-Ghorafi, M.A. Rosuvastatin-excipient compatibility studies for advanced drug delivery systems development. World J. Pharm. Res. 2024, 13(13), 1549–1582. DOI: 10.20959/wjpr202413-33126

20. Vijaya, V.; Karunai Selvi, B. K.; Arockia John, P.J.; Ramya, S.; Jayakumararaj, R. Phytochemical screening, GC-MS and FTIR analysis of bioactive compounds in methanolic leaf extracts of Costus igneus (CIMLE) as a natural source of drug lead molecules for next-generation drug-design, development and therapeutics. J. Drug Deliv. Ther. 2022, 12(5-S), 142–155. DOI: 10.22270/jddt.v12i5-s.5658

21. Muthukumar, C.; Cathrine, L.; Gurupriya, S. Qualitative and quantitative phytochemical analysis of Costus igneus leaf extract. J. Pharmacogn. Phytochem. 2019, 8(4), 1595–1598.

22. Bharathi, J. K.; Prakash, M. A. S. Phytochemical screening and quantitative analysis, FTIR and GC-MS analysis of Costus pictus D. Don ex Lindl. leaf extracts – A potential therapeutic herb. J. Indian Chem. Soc. 2024, 101(11), Art. No: 101362. DOI: 10.1016/j.jics.2024.101362

23. Khandagale Sandip Suresh, Mahalkar Ram Babasaheb, Madane Somnath Jotiram, Patil Onkar Ganpat, Dabhade Sakshi kailasrao, Salve Dvitiya Shantilal. To study the preparation, formulation and evaluation of medicated lollipop. Int. J. Pharm. Sci. 2024, 2(5), 1275–1291. DOI: 10.5281/zenodo.11264459

24. Rao, N. B.; Gajula, R. G.; Sujatha, E.; Kumari, O. S. Phytochemical analysis and anti-microbial activity of Costus igneus (insulin plant) leaf extract. Int. J. Biol. Pharm. Allied Sci. 2016, 5(6), 1207–1214.

25. Bedse, A.; Nalawade, A.; Dhamane, S.; Kachave, R. N.; Wagh, V.; Tare, H.; Ghangale, G. Formulation and evaluation of herbal remedy for cough. Int. J. Pharm. Qual. Assur. 2023, 14(3), 762–766. DOI: 10.25258/ijpqa.14.3.51.

26. Cunha, F. A. B.; Matias, E. F. F.; Brito, S. V.; Ferreira, F. S.; Braga, J. M. A.; Costa, J. G. M.; Coutinho, H. D. M. Phytochemical screening, antibacterial activity and in vitro interactions between Costus cf. arabicus L. with UV-A and aminoglycosides. Nat. Prod. Res. 2012, 26(4), 380–386. DOI: 10.1080/14786419.2010.545776.

27. Sahoo, M. R.; Srinivasan, U. M.; Varier, R. R. Development and evaluation of Talisapatradi and Vyoshadi Choorna lozenges—An Ayurvedic traditional formulation. J. Rep. Pharm. Sci. 2022, 11(1), 110–117. DOI: 10.4103/jrptps.JRPTPS_80_21.

28. Chowdary, A. R.; Raaththika, R.; Vijayalakshmi, P. Evaluation of the cookies formulated with Costus igneus plant material for antidiabetic activity. Medico-Legal Update 2020, 20(3), 265-271.

29. Choppala, P. B.; Gera, V. N.; Inakoti, R. K.; Malakondaiah, G. Costus igneus oro-herbal films: Innovative and cost-effective therapy. Int. J. Food Nutr. Sci. 2022, 11(11), 3962-3974.

30. Ding, Y.; Chu, N.-n.; Wang, R.; Qin, W.; Shi, Y.-f.; Qian, Z.-z.; Liu, B.; He, Q. Pharmacokinetic and pharmacodynamic evaluation study of etomidate: a randomized, open-label, 2-period crossover study in healthy Chinese subjects. Sci. Rep. 2024, 14, Art. No: 7071. DOI: 10.1038/s41598-024-57581-2.

31. Hock, F. J.; Gralinski, M. R. (Eds.). Drug Discovery and Evaluation: Methods in Clinical Pharmacology, Living Reference Work; Springer Nature: 2020.

Saidatri Arige

drvsai@gecgudlavallerumic.in

Affiliation:

a:1:{s:5:"en_US";s:42:"V. V. Institute of Pharmaceutical Sciences";} India